Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 in Japanese Patients with Relapsing Multiple Sclerosis
NCT00537082Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Sep 2007; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00537082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537082.